Skip to main content

Table 6 Comparison of adipokine serum levels at study entry in patients with or without disease progression

From: Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease : a prospective cohort study

 

Total patients (N = 147)

Progressed (N = 47)

Not progressed (N = 100)

p-value

Leptin, ng/mL

6.60 [4.20–11.70]

6.40 [3.60–10.70]

6.85 [4.33–12.33]

0.160

Adiponectin, μg/mL

9.58 [6.65–11.88]

10.10 [7.18–13.67]

9.27 [6.52–11.75]

0.337

Leptin/adiponectin ratio, ng/μg

0.76 [0.39–1.44]

0.58 [0.39–1.24]

0.94 [0.42–1.60]

0.089

Leptin/total body fat, ng/mL/kg

0.56 [0.40–0.75]

0.60 [0.43–0.82]

0.53 [0.37–0.72]

0.086

Adiponectin/total body fat, μg/mL/kg

0.72 [0.44–1.15]

0.82 [0.63–1.26]

0.60 [0.38–1.11]

0.020

  1. Data are presented as median [interquartile range]